Header Logo

Connection

SARVARI YELLAPRAGADA to Stem Cell Transplantation

Back to Details
This is a "connection" page, showing publications SARVARI YELLAPRAGADA has written about Stem Cell Transplantation.
SARVARI YELLAPRAGADA
Connection Strength
0.026
Stem Cell Transplantation
  1. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.